Delivery Order #SPE2DP26F3239

Delivery Order for Hydrocortisone Supply under Definitive Pharmaceutical Contract

This award represents a delivery order under a pre-existing definitive pharmaceutical supply contract, specifically targeting the procurement of hydrocortisone acetate. The recipient, DMS Pharmaceutical Group Inc., is a distributor focused on delivering pharmaceutical products critical to federal health agencies. This delivery order facilitates the timely provision of hydrocortisone, a topical corticosteroid important in treating inflammatory conditions, contributing significantly to ongoing public health needs. The scope covers the supply and delivery of this medication within a concise performance window, ensuring prompt availability. This order falls under a competitively managed indefinite delivery vehicle (IDV) contract established earlier, highlighting its role in a strategic, sustained pharmaceutical procurement approach. The delivery order's solid integration within the larger, substantial pharmaceutical contract underscores its importance for maintaining continuous medical treatment supplies. The contract performance is scheduled for a brief term during early March 2026, reflecting a focused supply effort within an ongoing multi-year agreement.

Description

8511951988!HYDROCORTISONE ACET

View original record